Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005767,
umls-concept:C0007589,
umls-concept:C0007807,
umls-concept:C0015982,
umls-concept:C0075029,
umls-concept:C0086045,
umls-concept:C0205224,
umls-concept:C0243125,
umls-concept:C0348026,
umls-concept:C0549193,
umls-concept:C0699900,
umls-concept:C0722236,
umls-concept:C1511938,
umls-concept:C1514468
|
pubmed:issue |
1
|
pubmed:dateCreated |
1978-6-12
|
pubmed:abstractText |
The fibrin(ogen) degradation product concentration is another differential-diagnosis parameter for distinguishing between artificially blood-stained and essentially blood-stained CSF. Determination of the fibrin(ogen) degradation product concentration has been found to be a reliable method of recognizing natively and artificially blood-stained CSF as being different.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0033-2739
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
36-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1978
|
pubmed:articleTitle |
[Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
|
pubmed:publicationType |
Journal Article,
English Abstract
|